A. D. Beadell Investment Counsel, Inc. Merck & Co., Inc. Transaction History

A. D. Beadell Investment Counsel, Inc.

  • $125 Million
  • Q3 2024

A detailed history of A. D. Beadell Investment Counsel, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, A. D. Beadell Investment Counsel, Inc. holds 32,556 shares of MRK stock, worth $3.23 Million. This represents 2.95% of its overall portfolio holdings.

Number of Shares
32,556
Previous 32,705 0.46%
Holding current value
$3.23 Million
Previous $4.05 Million 8.67%
% of portfolio
2.95%
Previous 3.39%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024
SELL
$111.15 - $128.97 $16,561 - $19,216
-149 Reduced 0.46%
32,556 $3.7 Million
Q2 2024

Jul 12, 2024
SELL
$123.8 - $132.96 $123,552 - $132,694
-998 Reduced 2.96%
32,705 $4.05 Million
Q1 2024

Apr 12, 2024
BUY
$113.24 - $131.95 $113 - $131
1 Added 0.0%
33,703 $4.45 Million
Q4 2023

Jan 18, 2024
SELL
$100.18 - $109.02 $23,842 - $25,946
-238 Reduced 0.7%
33,702 $3.67 Million
Q3 2023

Oct 13, 2023
SELL
$102.95 - $114.33 $1.19 Million - $1.32 Million
-11,518 Reduced 25.34%
33,940 $3.49 Million
Q2 2023

Jul 13, 2023
SELL
$108.61 - $118.38 $825,327 - $899,569
-7,599 Reduced 14.32%
45,458 $5.25 Million
Q1 2023

Apr 12, 2023
SELL
$102.94 - $114.86 $103,145 - $115,089
-1,002 Reduced 1.85%
53,057 $5.64 Million
Q4 2022

Jan 12, 2023
SELL
$87.44 - $112.11 $161,676 - $207,291
-1,849 Reduced 3.31%
54,059 $6 Million
Q3 2022

Oct 13, 2022
BUY
$84.53 - $94.96 $83,262 - $93,535
985 Added 1.79%
55,908 $4.81 Million
Q2 2022

Jul 15, 2022
SELL
$83.49 - $94.64 $268,253 - $304,078
-3,213 Reduced 5.53%
54,923 $5.01 Million
Q1 2022

Apr 12, 2022
SELL
$73.51 - $82.4 $53,221 - $59,657
-724 Reduced 1.23%
58,136 $4.77 Million
Q4 2021

Jan 19, 2022
BUY
$72.28 - $90.54 $734,870 - $920,520
10,167 Added 20.88%
58,860 $4.51 Million
Q3 2021

Oct 13, 2021
SELL
$71.68 - $78.83 $4,515 - $4,966
-63 Reduced 0.13%
48,693 $3.66 Million
Q2 2021

Jul 29, 2021
BUY
$70.31 - $77.77 $17,366 - $19,209
247 Added 0.51%
48,756 $3.79 Million
Q1 2021

Apr 15, 2021
BUY
$68.86 - $81.11 $584,414 - $688,380
8,487 Added 21.21%
48,509 $3.74 Million
Q4 2020

Jan 15, 2021
SELL
$71.77 - $79.65 $65,597 - $72,800
-914 Reduced 2.23%
40,022 $3.27 Million
Q3 2020

Nov 02, 2020
BUY
$73.18 - $82.95 $44,054 - $49,935
602 Added 1.49%
40,936 $3.4 Million
Q2 2020

Jul 15, 2020
BUY
$70.42 - $80.13 $1.08 Million - $1.23 Million
15,305 Added 61.15%
40,334 $3.12 Million
Q1 2020

Apr 22, 2020
BUY
$63.36 - $87.82 $170,565 - $236,411
2,692 Added 12.05%
25,029 $1.93 Million
Q4 2019

Feb 04, 2020
BUY
$77.58 - $87.54 $680,066 - $767,375
8,766 Added 64.59%
22,337 $2.03 Million
Q3 2019

Oct 24, 2019
BUY
$76.08 - $82.93 $76 - $82
1 Added 0.01%
13,571 $1.14 Million
Q2 2019

Jul 17, 2019
BUY
$69.84 - $81.59 $139 - $163
2 Added 0.01%
13,570 $1.14 Million
Q1 2019

Apr 24, 2019
BUY
$69.58 - $79.36 $69 - $79
1 Added 0.01%
13,568 $1.13 Million
Q4 2018

Feb 05, 2019
SELL
$65.24 - $75.71 $52,126 - $60,492
-799 Reduced 5.56%
13,567 $1.04 Million
Q3 2018

Oct 23, 2018
SELL
$57.69 - $67.84 $57,574 - $67,704
-998 Reduced 6.5%
14,366 $1.02 Million
Q2 2018

Jul 19, 2018
BUY
$50.83 - $59.72 $50 - $59
1 Added 0.01%
15,364 $932,000
Q1 2018

Apr 25, 2018
SELL
$50.96 - $59.23 $3,974 - $4,619
-78 Reduced 0.51%
15,363 $836,000
Q4 2017

Feb 06, 2018
BUY
$51.62 - $61.64 $112,841 - $134,745
2,186 Added 16.49%
15,441 $868,000
Q3 2017

Oct 25, 2017
BUY
$58.67 - $63.13 $777,670 - $836,788
13,255
13,255 $848,000

Others Institutions Holding MRK

# of Institutions
3,820
Shares Held
1.88B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track A. D. Beadell Investment Counsel, Inc. Portfolio

Follow A. D. Beadell Investment Counsel, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of A. D. Beadell Investment Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on A. D. Beadell Investment Counsel, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email